We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.28B
AUM Growth
-$525M
Cap. Flow
-$73.7M
Cap. Flow %
-3.24%
Top 10 Hldgs %
24.97%
Holding
2,489
New
246
Increased
163
Reduced
899
Closed
122

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$12.9M
2
AAPL icon
Apple
AAPL
+$4.61M
3
MSFT icon
Microsoft
MSFT
+$3.3M
4
T icon
AT&T
T
+$3.04M
5
CERN
Cerner Corp
CERN
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 21.39%
2 Healthcare 13.76%
3 Financials 11.85%
4 Consumer Discretionary 9.19%
5 Industrials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRSR icon
1776
Corsair Gaming
CRSR
$1.45B
$32.3K ﹤0.01%
2,459
+495
+25% +$8.08K
OSCR icon
1777
Oscar Health
OSCR
$9.5B
$32.2K ﹤0.01%
+7,588
New +$48.3K
ZGN icon
1778
Zegna
ZGN
$3.73B
$32.2K ﹤0.01%
+3,056
New +$31.3K
SOVO
1779
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$32.2K ﹤0.01%
2,031
NWLI
1780
DELISTED
National Western Life Group, Inc. Class A
NWLI
$32.2K ﹤0.01%
159
GSBC icon
1781
Great Southern Bancorp
GSBC
$888M
$32.1K ﹤0.01%
549
-190
-26% -$11.1K
MXCT icon
1782
MaxCyte
MXCT
$149M
$31.9K ﹤0.01%
6,739
OFIX icon
1783
Orthofix Medical
OFIX
$415M
$31.9K ﹤0.01%
1,354
NFBK
1784
DELISTED
Northfield Bancorp
NFBK
$31.9K ﹤0.01%
2,446
TTI icon
1785
TETRA Technologies
TTI
$1.25B
$31.8K ﹤0.01%
7,825
TSVT
1786
DELISTED
2seventy bio
TSVT
$31.7K ﹤0.01%
2,405
+931
+63% +$12.7K
CLAR icon
1787
Clarus
CLAR
$145M
$31.7K ﹤0.01%
1,671
RES icon
1788
RPC Inc
RES
$1.39B
$31.5K ﹤0.01%
4,559
BV icon
1789
BrightView Holdings
BV
$1.08B
$31.4K ﹤0.01%
2,617
RLMD icon
1790
Relmada Therapeutics
RLMD
$507M
$31.4K ﹤0.01%
1,651
INGN icon
1791
Inogen
INGN
$154M
$31.3K ﹤0.01%
1,296
KE
1792
Kimball Electronics
KE
$626M
$31.2K ﹤0.01%
1,554
EBIX
1793
DELISTED
Ebix Inc
EBIX
$31.2K ﹤0.01%
1,845
RMR icon
1794
The RMR Group
RMR
$346M
$31.1K ﹤0.01%
1,097
THFF icon
1795
First Financial Corp
THFF
$975M
$31.1K ﹤0.01%
698
+128
+22% +$5.6K
CNXN icon
1796
PC Connection
CNXN
$2.04B
$31K ﹤0.01%
704
CSTL icon
1797
Castle Biosciences
CSTL
$933M
$30.9K ﹤0.01%
1,410
ORC
1798
Orchid Island Capital
ORC
$1.32B
$30.9K ﹤0.01%
2,171
+497
+30% +$7.38K
SRI icon
1799
Stoneridge
SRI
$201M
$30.9K ﹤0.01%
1,802
TITN icon
1800
Titan Machinery
TITN
$420M
$30.9K ﹤0.01%
1,377

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2022 Portfolio in Review

As of Q2 2022, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $2.28B, down 19% from $2.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $73.7M in Q2 2022, closing 122 positions and reducing 899 holdings. Its most notable exit was Cerner Corp, an estimated $1.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Keurig Dr Pepper worth $1.56M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2022 buy was Keurig Dr Pepper: 44,056 shares worth $1.56M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.7M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $12.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Cerner Corp in Q2 2022, selling an estimated $1.7M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 25% of its $2.28B portfolio in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 246 new positions and closed 122 in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 19% quarter-over-quarter to $2.28B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.